FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283158632> ?p ?o ?g. }

• W4283158632 endingPage "003685042211051" @default.
• W4283158632 startingPage "003685042211051" @default.
• W4283158632 abstract "Direct-acting antiviral (DAA) regimens and telemedicine services are both options for treating hepatitis C virus (HCV) within the prison setting. We aimed to compare factors associated with HCV treatment success over the past decade in Israeli prisons, specifically the influence of DAAs and telemedicine.We retrospectively reviewed the medical records of inmates with HCV infection in Israeli prisons from 2010 through 2020. Demographic, clinical, and laboratory data were recorded, including treatment regimens and success rates.A total of 273 inmates were treated; mean age 45 ± 9.36 years; 98.2% males; 63.9% with a history of drug abuse. Advanced fibrosis was documented in 42.9%. The most common genotypes were 1 (46%) followed by 3 (40.7%). Interferon-based regimens were given to 68 inmates between 2010 and 2017. DAA agents were introduced in 2016, with pan-genotype regimens being exclusively used since 2019. Telemedicine services were used in 140 patients (51.3%), starting in February 2019. The sustained viral response (SVR) rate with interferon-based therapy was 78.8% and 98.8% with DAA treatment, giving an overall SVR of 93.2%. This difference between regimens proved to be the only statistically significant predictor of treatment success. The number of prisoners being treated with DAAs increased exponentially after telemedicine was introduced. Comparable SVR rates were achieved with either in-person or telemedicine consultation.Screening of this high-risk population and using telemedicine for treatment may be an effective strategy for the elimination of HCV from the prison population." @default.
• W4283158632 created "2022-06-21" @default.
• W4283158632 creator A5011632526 @default.
• W4283158632 creator A5016294618 @default.
• W4283158632 creator A5019348308 @default.
• W4283158632 creator A5029114028 @default.
• W4283158632 creator A5036459693 @default.
• W4283158632 creator A5046568830 @default.
• W4283158632 creator A5059061843 @default.
• W4283158632 creator A5069086617 @default.
• W4283158632 creator A5072449522 @default.
• W4283158632 date "2022-04-01" @default.
• W4283158632 modified "2023-09-29" @default.
• W4283158632 title "The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons" @default.
• W4283158632 cites W1853325270 @default.
• W4283158632 cites W1988986320 @default.
• W4283158632 cites W2044923938 @default.
• W4283158632 cites W2058440689 @default.
• W4283158632 cites W2064387090 @default.
• W4283158632 cites W2073065905 @default.
• W4283158632 cites W2077227075 @default.
• W4283158632 cites W2090447556 @default.
• W4283158632 cites W2117534340 @default.
• W4283158632 cites W2119425622 @default.
• W4283158632 cites W2143718001 @default.
• W4283158632 cites W2245918563 @default.
• W4283158632 cites W2416441980 @default.
• W4283158632 cites W2519295339 @default.
• W4283158632 cites W2529503072 @default.
• W4283158632 cites W2559771209 @default.
• W4283158632 cites W2724995126 @default.
• W4283158632 cites W2741503842 @default.
• W4283158632 cites W2792715405 @default.
• W4283158632 cites W2793877388 @default.
• W4283158632 cites W2811254448 @default.
• W4283158632 cites W2821465432 @default.
• W4283158632 cites W2889716957 @default.
• W4283158632 cites W2890778396 @default.
• W4283158632 cites W2896951337 @default.
• W4283158632 cites W2897554558 @default.
• W4283158632 cites W2949344542 @default.
• W4283158632 cites W2984385682 @default.
• W4283158632 cites W2990578624 @default.
• W4283158632 cites W3027483980 @default.
• W4283158632 cites W3042316724 @default.
• W4283158632 cites W3048332638 @default.
• W4283158632 cites W3094300265 @default.
• W4283158632 cites W3100012317 @default.
• W4283158632 cites W3109461289 @default.
• W4283158632 cites W3130360537 @default.
• W4283158632 doi "https://doi.org/10.1177/00368504221105173" @default.
• W4283158632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35722762" @default.
• W4283158632 hasPublicationYear "2022" @default.
• W4283158632 type Work @default.
• W4283158632 citedByCount "2" @default.
• W4283158632 countsByYear W42831586322023 @default.
• W4283158632 crossrefType "journal-article" @default.
• W4283158632 hasAuthorship W4283158632A5011632526 @default.
• W4283158632 hasAuthorship W4283158632A5016294618 @default.
• W4283158632 hasAuthorship W4283158632A5019348308 @default.
• W4283158632 hasAuthorship W4283158632A5029114028 @default.
• W4283158632 hasAuthorship W4283158632A5036459693 @default.
• W4283158632 hasAuthorship W4283158632A5046568830 @default.
• W4283158632 hasAuthorship W4283158632A5059061843 @default.
• W4283158632 hasAuthorship W4283158632A5069086617 @default.
• W4283158632 hasAuthorship W4283158632A5072449522 @default.
• W4283158632 hasConcept C126322002 @default.
• W4283158632 hasConcept C159047783 @default.
• W4283158632 hasConcept C160735492 @default.
• W4283158632 hasConcept C162324750 @default.
• W4283158632 hasConcept C166957645 @default.
• W4283158632 hasConcept C2522874641 @default.
• W4283158632 hasConcept C2776408679 @default.
• W4283158632 hasConcept C2776455275 @default.
• W4283158632 hasConcept C2779891985 @default.
• W4283158632 hasConcept C2780656516 @default.
• W4283158632 hasConcept C2908647359 @default.
• W4283158632 hasConcept C50522688 @default.
• W4283158632 hasConcept C71924100 @default.
• W4283158632 hasConcept C95457728 @default.
• W4283158632 hasConcept C99454951 @default.
• W4283158632 hasConceptScore W4283158632C126322002 @default.
• W4283158632 hasConceptScore W4283158632C159047783 @default.
• W4283158632 hasConceptScore W4283158632C160735492 @default.
• W4283158632 hasConceptScore W4283158632C162324750 @default.
• W4283158632 hasConceptScore W4283158632C166957645 @default.
• W4283158632 hasConceptScore W4283158632C2522874641 @default.
• W4283158632 hasConceptScore W4283158632C2776408679 @default.
• W4283158632 hasConceptScore W4283158632C2776455275 @default.
• W4283158632 hasConceptScore W4283158632C2779891985 @default.
• W4283158632 hasConceptScore W4283158632C2780656516 @default.
• W4283158632 hasConceptScore W4283158632C2908647359 @default.
• W4283158632 hasConceptScore W4283158632C50522688 @default.
• W4283158632 hasConceptScore W4283158632C71924100 @default.
• W4283158632 hasConceptScore W4283158632C95457728 @default.
• W4283158632 hasConceptScore W4283158632C99454951 @default.
• W4283158632 hasIssue "2" @default.
• W4283158632 hasLocation W42831586321 @default.

• next